Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2019 09:15 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Presents Data at the 26th International Symposium on Hepatitis C Virus and Related Viruses

- Novel class of HCV antivirals targeting the NS3 helicase that can be studied for the treatment of chronic HCV infection developed utilizing Company’s unique structure-based drug design platform...